Logo.png
Guardion Health Sciences Announces
May 13, 2024 17:01 ET | Guardion Health Sciences, Inc.
-- Financial Results for the Three Months Ended March 31, 2024 -- Institutional Shareholder Services Issues Report Recommending that Institutional Stockholders Vote in Favor of All Proposals at...
HorizonBancorpInc_SM.jpg
Horizon Bancorp, Inc. Names John R. Stewart, CFA as Chief Financial Officer
May 13, 2024 17:00 ET | Horizon Bancorp, Inc.
Horizon Bancorp, Inc. names John R. Stewart as new Chief Financial Officer
wordmark_black_BRLT (1).png
Brilliant Earth Announces Participation in 19th Annual Needham Technology, Media, & Consumer Conference
May 13, 2024 16:59 ET | Brilliant Earth, LLC
SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today...
ogsk2sgeyptxenjnnf5a.png
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
May 13, 2024 16:58 ET | Orchestra BioMed Holdings, Inc.
Company hosting in-person R&D day event, focused on atrioventricular interval modulation (“AVIM”) therapy, including the unmet need in hypertension, mechanism of action, clinical results and...
allogene.png
Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
May 13, 2024 16:47 ET | Allogene Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T...
logo (003).jpg
Astrotech Reports Third Quarter of Fiscal Year 2024 Financial Results
May 13, 2024 16:45 ET | Astrotech Corporation
AUSTIN, Texas, May 13, 2024 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the third quarter of fiscal year 2024, which...
IKNA.png
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
May 13, 2024 16:45 ET | Ikena Oncology, Inc.
Strong financial position with $157.3 million; runway into 2H 2026 IK-930 program on track to deliver clinical update in 2H 2024 IK-595 program continues dose escalation in patients with RAS...
Jamf-color-CMYK.jpg
Jamf Announces Launch of Secondary Offering of Common Stock by Selling Stockholders and Related Common Stock Repurchase
May 13, 2024 16:42 ET | Jamf
MINNEAPOLIS, May 13, 2024 (GLOBE NEWSWIRE) -- Jamf (Nasdaq: JAMF), the standard in managing and securing Apple at work, today announced the commencement of an underwritten public offering (the...
Zapata_Logo_NEW.jpg
Zapata Computing Holdings Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 13, 2024 16:36 ET | Zapata Computing, Inc.
BOSTON, May 13, 2024 (GLOBE NEWSWIRE) -- Zapata Computing Holdings Inc. (“Zapata AI” or the “Company”) (Nasdaq: ZPTA), the Industrial Generative AI company, today announced that the Compensation...
Integra-Promotional-Logos_Integra-Logo-Full-Color-Process (1).png
Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
May 13, 2024 16:30 ET | Integra LifeSciences Holdings Corporation
PRINCETON, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief...